{
    "title": "U.S. FDA approves Genmab-AbbVie's blood cancer therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12103889/US-FDA-approves-Genmab-AbbVies-blood-cancer-therapy.html",
    "date": "2023-05-19",
    "keywords": [
        "therapy",
        "drug",
        "cancer",
        "treatment",
        "approval",
        "administration",
        "drugmaker",
        "blood",
        "fda",
        "price",
        "month",
        "analyst",
        "deal",
        "food",
        "inc",
        "adult",
        "friday",
        "epcoritamab",
        "brand",
        "name",
        "type",
        "bcell",
        "firstofitskind",
        "disease",
        "glofitamab",
        "review",
        "set",
        "list",
        "epkinly",
        "duration",
        "product",
        "pipeline",
        "blow",
        "competition",
        "flagship",
        "humira",
        "peter",
        "peak",
        "race",
        "market",
        "bestinclass",
        "efficacy",
        "convenient",
        "yaron",
        "note",
        "midstage",
        "study",
        "injection",
        "skin",
        "size",
        "abbvie",
        "genmab",
        "part",
        "antibody",
        "share",
        "japan",
        "commercialization",
        "reporting",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}